Show sidebar
Show 9 12 18 24
Compare
Quick view
Add to wishlist

Buy Tecentriq (atezolizumab)

€3,604.50
Select options This product has multiple variants. The options may be chosen on the product page
Tecentriq (atezolizumab) is a medicine used to treat locally advanced or metastatic urothelial carcinoma, metastatic non-small cell lung cancer (NSCLC) and advanced triple-negative breast cancer (TNBC).